Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Neurolutions, Inc
- Proposal award date
- 2021-09-23
- Contract end date
- 2022-04-30
- UEI
- HCF7LKF9KN64
- Solicitation number
- PA20-262
- Topic code
- NICHD
Research abstract
Abstract. A substantial unmet clinical need and large commercial opportunity centers on chronic stroke patients’
poor access to advanced rehabilitation care [1, 2]. In rehabilitating chronically motor-impaired stroke survivors
with a brain computer interface (BCI), the current barrier for further advancement of telehealth BCI-driven
neurorehabilitation is that there is no integrated software and hardware system that is easily deployable to
screen, treat, and track chronic stroke patients in their home environments. Our company Neurolutions’ long-
term goal of this research is to create a widely scalable BCI rehabilitation solution that can restore function to
patients with a chronic stroke-induced motor deficit. Thus, creating and vetting a technical infrastructure to enable
remote acquisition/analysis of a patient’s brain signals and their motor function is essential to achieving this goal.
The objective of this proposal is to create a mail-delivered, internet-connected system that enables home-based
EEG screening for BCI-rehab candidacy and remote motor assessment of upper extremity response to BCI-
rehab treatment. Our central hypothesis is that fully remote assessment, enrollment, and treatment of chronic
stroke patients with an upper extremity motor deficit with the use of a BCI-controlled robotic hand exoskeleton
will demonstrate significant improvement in hand function. Thus, the rationale is that enabling patients to be
effectively screened, treated and monitored at home removes the need for patients to travel to health care
environments and thus enables a much larger population to access this technology. With extensive experience
in stroke-BCI and home-based care [3], we are well prepared to pursue the objective of this proposal with the
following Specific Aims: 1) Create a home-based EEG screening system for chronic stroke patients to determine
candidacy for BCI rehabilitation of upper extremity motor deficit, 2) Create a home-based system for performing
physical motor assessments that are equivalent to standard in-person Fugl-Meyer (FM) assessment of upper
extremity function, 3) Define the accuracy of home-based Fugl-Meyer (FM) assessment against gold standard
in-person FM assessment, and 4) Define the efficacy of fully remote home-based BCI therapy in chronic
hemiparetic subcortical stroke patients. This project is innovative because 1) it represents a departure from the
status quo by expanding the role the unaffected hemisphere can play in BCI-mediated stroke rehabilitation and
2) the focus on full course of treatment (screening, treatment and monitoring) occurring in the home significantly
departs from the commercial models of how advanced BCI-mediated rehabilitation is delivered. This project will
leverage the core Neurolutions BCI rehabilitation technology, the IpsiHand, which was recently given a
Breakthrough Device designation by the FDA. The proposed research will be significant because the creation of
an integrated system that can assess and treat chronic stroke patients remotely will radically increase access
and therapeutic benefit to a much larger percent of this underserved population. Collectively, the successful
execution of this project will reduce the personal and social burden of stroke for millions of Americans.Project Narrative
The proposed research is relevant to public health because developing a technology solution that enhances
access to neuroprosthetic rehabilitation of chronic stroke will fundamentally expand the number of patients that
can be treated with these advanced approaches to induce a functional recovery. Thus, the proposed research
is relevant to the NINDS mission, which is to reduce the burden of the neurologic disease of stroke.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
2 SBIR/STTR records share this UEI (2021–2022). Reported award amounts total $1,958,129. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards